Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)
International Journal of Oncology · 2025
DOI: 10.3892/ijo.2025.5776 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Taoming Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, Sichuan 610213, P.R. Chi…. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 364 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Magnetic Resonance Imaging (MRI) relies on contrast agents to enhance image quality and diagnostic accuracy. Traditional metal‑based agents, such as gadolinium compounds, raise safety concerns due to potential toxicity and long‑term retention in the body. The present review examines recent advancements in non‑metal‑based MRI contrast agents, focusing on fluorine‑19 (19F) compounds, chemical exchange saturation transfer (CEST) agents, nitroxide radicals, and hyperpolarized carbon agents. It discussed the mechanisms by which these agents improve contrast, including their biocompatibility and ability to provide molecular and metabolic information. Key findings highlight the high specificity of19F agents due to negligible background signals, the capacity of CEST agents for molecular imaging without metals, nitroxide radicals' utility in redox‑sensitive imaging, and hyperpolarized 13C compounds' role in real‑time metabolic assessment. Despite challenges such as low sensitivity and technical complexities, these non‑metal‑based agents offer promising, safer alternatives with enhanced diagnostic capabilities, paving the way for more precise and personalized medical imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, Sichuan 610213, P.R. China.
Zitieren
APA
Du, T., Luo, H., Song, H., Lin, T., & Yu, Q. (2025). Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5776
Vancouver
Du T, Luo H, Song H, Lin T, Yu Q. Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5776
BibTeX
@article{Du2025,
author = {Du, Taoming and Luo, Haiyang and Song, Huizhen and Lin, Tao and Yu, Qin},
title = {Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)},
journal = {International Journal of Oncology},
year = {2025},
doi = {10.3892/ijo.2025.5776}
}
EUVIMED